153 related articles for article (PubMed ID: 28673330)
1. UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression.
Grant DJ; Chen Z; Howard LE; Wiggins E; De Hoedt A; Vidal AC; Carney ST; Squires J; Magyar CE; Huang J; Freedland SJ
BMC Cancer; 2017 Jul; 17(1):463. PubMed ID: 28673330
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.
Margaillan G; Lévesque É; Guillemette C
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):85-93. PubMed ID: 26385605
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.
Habibi M; Mirfakhraie R; Khani M; Rakhshan A; Azargashb E; Pouresmaeili F
Gene; 2017 Nov; 634():47-52. PubMed ID: 28882566
[TBL] [Abstract][Full Text] [Related]
4. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.
Bélanger A; Hum DW; Beaulieu M; Lévesque E; Guillemette C; Tchernof A; Bélanger G; Turgeon D; Dubois S
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):301-10. PubMed ID: 9699884
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.
Pâquet S; Fazli L; Grosse L; Verreault M; Têtu B; Rennie PS; Bélanger A; Barbier O
J Clin Endocrinol Metab; 2012 Mar; 97(3):E428-32. PubMed ID: 22170718
[TBL] [Abstract][Full Text] [Related]
6. Deletions of the androgen-metabolizing UGT2B genes have an effect on circulating steroid levels and biochemical recurrence after radical prostatectomy in localized prostate cancer.
Nadeau G; Bellemare J; Audet-Walsh É; Flageole C; Huang SP; Bao BY; Douville P; Caron P; Fradet Y; Lacombe L; Guillemette C; Lévesque E
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1550-7. PubMed ID: 21733997
[TBL] [Abstract][Full Text] [Related]
7. Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line.
Lévesque E; Beaulieu M; Guillemette C; Hum DW; Bélanger A
Endocrinology; 1998 May; 139(5):2375-81. PubMed ID: 9564848
[TBL] [Abstract][Full Text] [Related]
8. The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer Progression.
Belledant A; Hovington H; Garcia L; Caron P; Brisson H; Villeneuve L; Simonyan D; Têtu B; Fradet Y; Lacombe L; Guillemette C; Lévesque E
Eur Urol; 2016 Apr; 69(4):601-609. PubMed ID: 26215610
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells.
Guillemette C; Lévesque E; Beaulieu M; Turgeon D; Hum DW; Bélanger A
Endocrinology; 1997 Jul; 138(7):2998-3005. PubMed ID: 9202245
[TBL] [Abstract][Full Text] [Related]
10. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution.
Gauthier-Landry L; Bélanger A; Barbier O
J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263
[TBL] [Abstract][Full Text] [Related]
11. Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.
Chouinard S; Pelletier G; Bélanger A; Barbier O
Endocr Res; 2004 Nov; 30(4):717-25. PubMed ID: 15666817
[TBL] [Abstract][Full Text] [Related]
12. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.
Grosse L; Pâquet S; Caron P; Fazli L; Rennie PS; Bélanger A; Barbier O
Cancer Res; 2013 Dec; 73(23):6963-71. PubMed ID: 24121496
[TBL] [Abstract][Full Text] [Related]
13. Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.
Lévesque E; Labriet A; Hovington H; Allain ÉP; Melo-Garcia L; Rouleau M; Brisson H; Turcotte V; Caron P; Villeneuve L; Leclercq M; Droit A; Audet-Walsh E; Simonyan D; Fradet Y; Lacombe L; Guillemette C
Br J Cancer; 2020 Mar; 122(7):1068-1076. PubMed ID: 32047296
[TBL] [Abstract][Full Text] [Related]
14. Expression of UDP Glucuronosyltransferases
Shafiee-Kermani F; Carney ST; Jima D; Utin UC; Farrar LB; Oputa MO; Hines MR; Kinyamu HK; Trotter KW; Archer TK; Hoyo C; Koller BH; Freedland SJ; Grant DJ
Epigenetics; 2021 Mar; 16(3):289-299. PubMed ID: 32660355
[TBL] [Abstract][Full Text] [Related]
15. Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.
Ménard V; Eap O; Harvey M; Guillemette C; Lévesque E
Hum Mutat; 2009 Sep; 30(9):1310-9. PubMed ID: 19572376
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.
Wijayakumara DD; Hu DG; Meech R; McKinnon RA; Mackenzie PI
J Pharmacol Exp Ther; 2015 Sep; 354(3):417-25. PubMed ID: 26163549
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
[TBL] [Abstract][Full Text] [Related]
18. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
[TBL] [Abstract][Full Text] [Related]
19. The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy.
Laverdière I; Flageole C; Audet-Walsh É; Caron P; Fradet Y; Lacombe L; Lévesque É; Guillemette C
Endocr Relat Cancer; 2015 Feb; 22(1):77-85. PubMed ID: 25452636
[TBL] [Abstract][Full Text] [Related]
20. Correlation between circulatory, local prostatic, and intra-prostatic androgen levels.
Olsson M; Ekström L; Guillemette C; Belanger A; Rane A; Gustafsson O
Prostate; 2011 Jun; 71(9):909-14. PubMed ID: 21541968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
